Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|January 19, 2024
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibitionShingo Satoh, Kotaro Miyake, Yuichi Adachi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 17, 2025
Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case reportDaiki Nagira, Satoshi Miyamoto, Taishiro Mizukoshi, et al.
JTO Clinical and Research Reports|June 7, 2023
Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLCTomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, et al.
Clinical Lung Cancer|November 15, 2017
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With NivolumabTakako Inoue, Motohiro Tamiya, Akihiro Tamiya, et al.
Plos One|February 23, 2018
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trialMotohiro Tamiya, Akihiro Tamiya, Takako Inoue, et al.
BMC Infectious Diseases|August 7, 2023
Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case reportMaiko Naito, Kentaro Fukushima, Shinsuke Kusakabe, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2022
Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with EmphysemaYuji Yamamoto, Haruhiko Hirata, Takayuki Shiroyama, et al.
Medicine|September 1, 2017
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysisYujiro Naito, Akihiro Tamiya, Motohiro Tamiya, et al.
Ebiomedicine|January 23, 2025
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugatesYuichi Adachi, Kotaro Miyake, Kika Ohira, et al.
Translational Lung Cancer Research|October 17, 2022
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studiesKinnosuke Matsumoto, Takayuki Shiroyama, Tomoki Kuge, et al.
Pageof 14